W

Ozempic, Zepbound and other GLP-1 drugs have a possible risk of vision loss

Business Management
Share
Ozempic, Zepbound and other GLP-1 drugs have a possible risk of vision loss

Several medical studies have found that people taking GLP-1 medications have an elevated risk for nonarteritic anterior ischemic optic neuropathy, or NAION.

Ozempic, Zepbound and other GLP-1 drugs have a possible risk of vision loss

Source：MarketWatch

Disclaimer：Please read market information rationally and stay aware of investment risks. All content on this site is for informational purposes only and does not constitute investment advice.

Related Reading

PNC Bank tests turning USDC payments into dollar deposits

The pilot lets eligible corporate and institutional clients accept USDC on Ethereum, with each token converted to one US dollar before deposit.…

Avalanche’s AVAX leads crypto gains following NYSE tokenization deal

Avalanche’s AVAX token rose as much as 10% after the NYSE selected its blockchain to support settlement on a planned tokenized stock trading platform.…

There is no one at Nvidia who would be ready to replace Jensen Huang

Nvidia’s CEO has an “outsize role and unclear succession.” Source：MarketWatch

Bitcoin, tech stocks brush off Nvidia nerves as analyst mulls $68K target

Bitcoin rebounded from an 11week low near $73,500 as the Nasdaq Composite rallied despite selloff in Nvidia shares. Source：Cointelegraph

Source：https://www.marketwatch.com/story/ozempic-zepbound-and-other-glp-1-drugs-have-a-possible-risk-of-vision-loss-b3738f36